GENEVA, July 9 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2026/010061) for “HIGH CONCENTRATION VEGF RECEPTOR FUSION PROTEIN CONTAINING BUFFER FREE FORMULATIONS”. With publication no. WO/2026/148214, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 9/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....